Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematometra associated with estrogen replacement therapy

P C Sacks1, R J Falk

  • 1Department of Obstetrics and Gynecology, Georgetown University School of Medicine, Washington, DC.

Southern Medical Journal
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Injection of ANCA-No Neutrophils, No Glomerular Damage: The Role of Neutrophils in the Induction of Glomerulonephritis by Anti-Myeloperoxidase Antibodies. Am J Pathol 167: 39-45, 2005.

Journal of the American Society of Nephrology : JASN·2023
Same author

Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.

Clinical and experimental immunology·2014
Same author

Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis.

Clinical and experimental rheumatology·2013
Same author

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Arthritis and rheumatism·2012
Same author

Epigenetics and complementary proteins.

Clinical and experimental immunology·2011
Same author

Leukocyte gene expression signatures in antineutrophil cytoplasmic autoantibody and lupus glomerulonephritis.

Kidney international·2007

Two cases of hematometra, a uterus filled with menstrual blood, occurred in women after starting estrogen therapy. This was due to cervical stenosis preventing flow, highlighting the need for cervical patency checks before hormone therapy.

Area of Science:

  • Gynecology
  • Reproductive Medicine
  • Hormone Therapy

Background:

  • Cervical stenosis can develop after prolonged hypoestrogenism.
  • Estrogen replacement therapy (ERT) is used for menopausal symptoms.
  • Sequential estrogen/progestin therapy is a common ERT regimen.

Observation:

  • Two cases of hematometra were observed post-ERT initiation.
  • Cervical stenosis was present in both patients.
  • Sonography confirmed asymptomatic hematometra.

Findings:

  • Cervical stenosis prevented menstrual flow after initiating sequential estrogen/progestin therapy.
  • Hematometra developed as a consequence of obstructed outflow.

Implications:

Related Experiment Videos

  • Baseline evaluation of cervical patency is recommended before initiating ERT in long-term postmenopausal women.
  • This evaluation may prevent complications like hematometra.
  • Further research into ERT protocols and cervical health is warranted.